DE69919597D1 - Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung - Google Patents
Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendungInfo
- Publication number
- DE69919597D1 DE69919597D1 DE69919597T DE69919597T DE69919597D1 DE 69919597 D1 DE69919597 D1 DE 69919597D1 DE 69919597 T DE69919597 T DE 69919597T DE 69919597 T DE69919597 T DE 69919597T DE 69919597 D1 DE69919597 D1 DE 69919597D1
- Authority
- DE
- Germany
- Prior art keywords
- formulations containing
- topical formulations
- skin penetration
- containing skin
- penetration agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14075699P | 1999-06-25 | 1999-06-25 | |
US140756P | 1999-06-25 | ||
PCT/US1999/022313 WO2001000139A1 (en) | 1999-06-25 | 1999-09-28 | Topical formulations comprising skin penetration agents and the use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69919597D1 true DE69919597D1 (de) | 2004-09-23 |
DE69919597T2 DE69919597T2 (de) | 2005-07-14 |
Family
ID=22492675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69919597T Expired - Lifetime DE69919597T2 (de) | 1999-06-25 | 1999-09-28 | Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung |
Country Status (15)
Country | Link |
---|---|
US (1) | US6271219B2 (de) |
EP (1) | EP1194109B1 (de) |
JP (1) | JP2003506462A (de) |
KR (1) | KR100623534B1 (de) |
AT (1) | ATE273682T1 (de) |
AU (1) | AU769079B2 (de) |
BR (1) | BR9917389B1 (de) |
CA (1) | CA2376850C (de) |
DE (1) | DE69919597T2 (de) |
DK (1) | DK1194109T3 (de) |
ES (1) | ES2224755T3 (de) |
MX (1) | MXPA01013460A (de) |
NZ (1) | NZ516765A (de) |
PT (1) | PT1194109E (de) |
WO (1) | WO2001000139A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
JP2006502213A (ja) | 2002-10-10 | 2006-01-19 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | 脂肪族アルコール類の塩基性エステルおよび抗炎症薬または免疫調整薬としての使用 |
US20050101605A1 (en) * | 2003-11-07 | 2005-05-12 | Ahmed Salah U. | Oral liquid formulations of methotrexate |
CA2586815A1 (en) * | 2004-11-29 | 2006-06-01 | Ambria Dermatology Ab | A composition comprising at least 3 different diols |
WO2008106092A1 (en) | 2007-02-26 | 2008-09-04 | Yeda Research And Development Co. Ltd. | Enantiomers of amino-phenyl-acetic acid octadec- 9- (z) enyl ester, their salts and their uses |
KR100987121B1 (ko) * | 2010-08-12 | 2010-10-12 | 연세대학교 산학협력단 | 창문닦기로봇 |
US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
US8853189B2 (en) | 2012-05-31 | 2014-10-07 | Prima Innovations, Llc | Antispasmodic 1,2-Diols and 1,2,3-triols |
CN105263474A (zh) * | 2013-06-03 | 2016-01-20 | 托马有限公司 | 皮质类固醇组合物 |
CN104161721A (zh) * | 2014-07-14 | 2014-11-26 | 湖北博康医药科技有限公司 | 一种用于治疗皮肤病的蛇王药剂及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE843140A (fr) | 1975-06-19 | 1976-10-18 | Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients | |
US4316893A (en) | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US4444762A (en) | 1980-04-04 | 1984-04-24 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacyclopentan-2-ones |
US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
US4552872A (en) | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
US4537776A (en) | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
US4886783A (en) | 1986-01-31 | 1989-12-12 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agents |
US5196410A (en) * | 1986-10-31 | 1993-03-23 | Pfizer Inc. | Transdermal flux enhancing compositions |
US4863970A (en) * | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
JPH0676328B2 (ja) * | 1987-04-14 | 1994-09-28 | 株式会社大塚製薬工場 | ステロイドクリ−ム製剤 |
ATE104554T1 (de) * | 1990-01-10 | 1994-05-15 | Hoffmann La Roche | Topische praeparate. |
JP3207212B2 (ja) * | 1991-03-01 | 2001-09-10 | 久光製薬株式会社 | 吸収促進剤およびこれを含有する外用剤 |
US5607691A (en) * | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
JPH06219947A (ja) * | 1993-01-26 | 1994-08-09 | Kinki Univ | 経皮投与製剤 |
US5601839A (en) | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
EP0971662A1 (de) * | 1996-10-30 | 2000-01-19 | TheraTech, Inc. | Fettsäureester von glycolsäure und deren salze als penetrationsverstärker |
-
1999
- 1999-09-28 DK DK99973935T patent/DK1194109T3/da active
- 1999-09-28 EP EP99973935A patent/EP1194109B1/de not_active Expired - Lifetime
- 1999-09-28 ES ES99973935T patent/ES2224755T3/es not_active Expired - Lifetime
- 1999-09-28 AT AT99973935T patent/ATE273682T1/de active
- 1999-09-28 NZ NZ516765A patent/NZ516765A/xx not_active IP Right Cessation
- 1999-09-28 JP JP2001515895A patent/JP2003506462A/ja active Pending
- 1999-09-28 US US09/406,918 patent/US6271219B2/en not_active Expired - Lifetime
- 1999-09-28 CA CA002376850A patent/CA2376850C/en not_active Expired - Fee Related
- 1999-09-28 BR BRPI9917389-1A patent/BR9917389B1/pt not_active IP Right Cessation
- 1999-09-28 AU AU60607/99A patent/AU769079B2/en not_active Ceased
- 1999-09-28 PT PT99973935T patent/PT1194109E/pt unknown
- 1999-09-28 DE DE69919597T patent/DE69919597T2/de not_active Expired - Lifetime
- 1999-09-28 KR KR1020017016610A patent/KR100623534B1/ko not_active IP Right Cessation
- 1999-09-28 MX MXPA01013460A patent/MXPA01013460A/es active IP Right Grant
- 1999-09-28 WO PCT/US1999/022313 patent/WO2001000139A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ATE273682T1 (de) | 2004-09-15 |
US20010001790A1 (en) | 2001-05-24 |
EP1194109A4 (de) | 2003-01-15 |
KR20020038595A (ko) | 2002-05-23 |
AU769079B2 (en) | 2004-01-15 |
AU6060799A (en) | 2001-01-31 |
NZ516765A (en) | 2003-04-29 |
KR100623534B1 (ko) | 2006-09-18 |
DE69919597T2 (de) | 2005-07-14 |
WO2001000139A1 (en) | 2001-01-04 |
CA2376850C (en) | 2009-11-17 |
ES2224755T3 (es) | 2005-03-01 |
JP2003506462A (ja) | 2003-02-18 |
PT1194109E (pt) | 2004-12-31 |
EP1194109B1 (de) | 2004-08-18 |
EP1194109A1 (de) | 2002-04-10 |
BR9917389B1 (pt) | 2013-04-24 |
US6271219B2 (en) | 2001-08-07 |
BR9917389A (pt) | 2002-03-05 |
CA2376850A1 (en) | 2001-01-04 |
DK1194109T3 (da) | 2004-10-25 |
MXPA01013460A (es) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1146070A (en) | Topical triethylenetetramine-containing pharmaceutical compositions and methods of use | |
PE20001032A1 (es) | Composiciones y metodos para tratar enfermedades pulmonares | |
CA1307207C (en) | Steroid lotion | |
ATE370730T1 (de) | Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung | |
ATE323473T1 (de) | Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon | |
MY135988A (en) | Additive for improving the water resistance of cosmetic or dermatological formulations | |
DE69520768D1 (de) | Pharmazeutische Zubereitungen, die Fluoxetin enthalten | |
ATE125445T1 (de) | Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten. | |
BR0204596A (pt) | Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada | |
DK1392329T3 (da) | Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom | |
SE9900961D0 (sv) | Novel compounds | |
DE69919597D1 (de) | Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung | |
DE69932939D1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
ATE358474T1 (de) | Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung | |
NO20024646L (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
DK0856312T3 (da) | Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme | |
ES2137125A1 (es) | La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal. | |
SE9602644D0 (sv) | New use | |
AR022017A1 (es) | Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica | |
IE810489L (en) | Composition for topical application | |
GEP20043231B (en) | Resorcinol Composition | |
JP2016501236A (ja) | 炎症性皮膚状態の予防および治療のための方法 | |
BR9608721A (pt) | Composição farmacêutica, e, processo para tratar inflamação | |
KR20000050667A (ko) | 피부 미백 및 피부 질환 치료를 위한 조성물 | |
IT1257884B (it) | Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: ECHO THERAPEUTICS,INC., FRANKLIN, MASS., US |